Position in AXGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,135,211
+$340,787 QoQ
Shares Held
24,577
+2.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#124
of 252 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $87,877,885 across 9 Medical Devices names. AXGN ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
593,845 | $53,885,495 | |
| 2 | SYK |
Stryker Corp
|
63,139 | $19,878,682 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
84,197 | $5,389,449 | |
| 4 | BSX |
Boston Scientific Corp
|
69,510 | $2,966,686 | |
| 5 | MDT |
Medtronic plc
|
29,052 | $2,272,737 | |
| 6 | EW |
Edwards Lifesciences Corp
|
14,372 | $1,300,091 | |
| 7 | AXGN |
Axogen, Inc.
This page
|
24,577 | $1,135,211 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
6,250 | $538,062 |
All Filings in AXGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,135,211 | 24,577 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $794,424 | 23,979 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,035,347 | 62,186 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,109,398 | 62,186 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $674,718 | 62,186 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,191,492 | 64,405 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,386,841 | 84,153 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,137,919 | 81,164 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||